These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16808100)

  • 21. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S88-102. PubMed ID: 19007655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of hormone replacement therapy in the prevention and treatment of menopausal osteoporosis].
    Landa MC
    An Sist Sanit Navar; 2003; 26 Suppl 3():99-105. PubMed ID: 14716362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Menopausal hormone treatment in 2011].
    Rozenberg S; Vandromme J; Antoine C
    Rev Med Brux; 2011 Sep; 32(4):239-42. PubMed ID: 22034751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
    Ettinger B
    Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A physiopathological overview of climacteric and menopause].
    Aranda Gallegos JE; Barrón Vallejo J; Ortega Díaz R; Pereyra Quiñones R; Kably Ambe A
    Ginecol Obstet Mex; 1998 Jun; 66():253-8. PubMed ID: 9679402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data].
    Gaspard U
    J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):340-5. PubMed ID: 18249506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
    Sitruk-Ware R
    Climacteric; 2007 Oct; 10(5):358-70. PubMed ID: 17852138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women.
    Chan MF; Dowsett M; Folkerd E; Wareham N; Luben R; Welch A; Bingham S; Khaw KT
    Menopause; 2008; 15(2):332-9. PubMed ID: 17667152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neurology of menopause.
    Henderson VW
    Neurologist; 2006 May; 12(3):149-59. PubMed ID: 16688016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmenopausal hormone therapy: who now takes it and do they differ from non-users?
    Taylor AW; MacLennan AH; Avery JC
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):128-35. PubMed ID: 16638035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
    Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harnessing hormonal signaling for cardioprotection.
    Ballard VL; Edelberg JM
    Sci Aging Knowledge Environ; 2005 Dec; 2005(51):re6. PubMed ID: 16371658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone therapy for women after breast cancer: a review.
    Levgur M
    J Reprod Med; 2004 Jul; 49(7):510-26. PubMed ID: 15305822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius J; Brincat MP
    Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.